Here’s What We’re Looking For From Ultragenyx Pharmaceutical Inc (RARE)

Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) just announced that it has completed enrollment in its pivotal study of its lead rickets candidate, and given us an idea of when it...

Keep Reading →